New Haven, CTNCT04366518Now EnrollingIRB Ready

Hallucinations, Auditory Clinical Trial in New Haven, CT

Access cutting-edge hallucinations, auditory treatment through this early phase 1 clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access hallucinations, auditory specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hallucinations, auditory treatment provided free

Apply for This New Haven Location

Check if you qualify for this hallucinations, auditory clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Hallucinations, Auditory Study in New Haven

Auditory hallucinations are among the most distressing aspects of psychotic illness, and between 10 and 30% of people with hallucinations do not respond to antipsychotic medications. The authors have used computational modeling of behavior to link brain activity to development of auditory hallucinations in the hope of guiding new treatment development. The proposed studies take the first step toward individualized treatment approaches to hallucinations by attempting causal, pharmacological manipulation of relevant model parameters underlying these phenomena.

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

English speaking
Right handedness
Diagnosed with schizophrenia schizoaffective, schizophreniform, schizotypal, or brief psychotic disorder
History of auditory verbal hallucinations occurring at least weekly

Exclusion Criteria

Current substance dependence or active use as determined by drug test.
Any neurological, medical or developmental problem that is known to impair cognition significantly
Contraindications for MR scanning including metallic implants of any kind, pacemakers and history of accidents with metal, claustrophobia
History of seizures
History of violence
History of suicide
Pregnancy (determined by urine pregnancy test)
Concurrent participation in any other intervention study
History of urinary retention
History of delirium
Current use of any cholinergic or anticholinergic medication
History of asthma, diabetes, and cardiovascular disease
Evidence of cardiovascular disease on EKG
Individuals who have been on dopamine-2 antagonists for less than 6 months (to limit risk of EPS)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT04366518) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hallucinations, Auditory Treatment Options in New Haven, CT

If you're searching for hallucinations, auditory treatment options in New Haven, CT, this clinical trial (NCT04366518) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced hallucinations, auditory specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hallucinations, auditory clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in New Haven, CT

See all leukemia clinical trials recruiting in New Haven — not just this study.

Browse Leukemia Trials in New Haven →

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT